SQI Diagnostics signs commercial contract with global biotech

By Melissa Fassbender contact

- Last updated on GMT

SQI develops custom research and diagnostic assays. (Image: iStock/JK1991)
SQI develops custom research and diagnostic assays. (Image: iStock/JK1991)

Related tags: Contract, Biotechnology

SQI Diagnostics Inc. has signed an agreement to commercialize a custom multiplexed assay for a Waltham, MA-based global biotechnology company's blood disorder drug program.

As part of the agreement, SQI will provide sample analysis and data reporting services on human study samples using a custom-developed test unique to the unnamed customers biologic therapeutic.

Russell Peloquin, vice president, Global Commercial Operations at SQI Diagnostics told us the custom assay provider is excited to begin the commercial relationship with the company, with which they have not worked before.

Contracts have been signed and a purchase order has been received​,” he said. “We are now awaiting reagents from the customer that are scheduled to arrive shortly​.”

Once the reagents are received, the company will complete its assay development processes and will begin receiving samples for analysis and reporting to the customer.

As a small company, Peloquin said it is constantly going head-to-head with incumbent platforms that have been around for years.

As part of target customers’ vetting process, we are being measured against these older technologies​,” he explained. However, as he said is demonstrated with the most recent commercial contract, Peloquin added, “the industry has gained enough confidence in not only our technology, but also in our unique and flexible business models to afford us credibility throughout the market​.”

Related news

Related products

show more

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

CAR-T Cell Therapy

CAR-T Cell Therapy

Q² Solutions | 01-Sep-2020 | Clinical Study

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q² Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Related suppliers

Follow us

Products

View more

Webinars